GenScript Bulk Antibody Production for CVV

The Centers for Disease Control and Prevention (CDC), the Vaccine Preparedness Team of the Virology, from the Virology Surveillance and Diagnosis Branch within the Influenza Division of the CDC intends to competitively procure through full and open competition of recombinant antibodies. The overall objective is to provide the Influenza Division with recombinant antibodies. The Vaccine Preparedness Team of the Virology, shall be the principal scientific and technical party representing the Government’s needs, working with an indetermined Contractor from selected Offerors. Requirements: Three hundred (300) screen-scale preparations of recombinant antibodies expressed in a 4 ml culture: 1. The CDC will provide a digital sequence. 2. Contractor to perform any gene synthesis and vector construction. 3. Each expression is to be done in a mammalian liquid culture with a volume of 4 mL. 4. Multiple antibodies will be requested at once, totaling 300 over one (1) year, with batch sizes likely in the 20-50 range, but could be significantly more or less. 5. Delivery of recombinant antibodies (batches) within 21 days of request. The Government will release the solicitation, including any subsequent amendments on the SAM.gov website. The Government anticipates the solicitation will be available approximately 5 days from the date of release of this notice, with an anticipated closing date/proposal due date of 10 days from the date of release of solicitation. No telephone or written requests for the solicitation will be accepted. After solicitation release, vendors should regularly access the website to access any updates.